Vericel (VCEL) Other Operating Expenses (2011 - 2025)

Vericel's (VCEL) quarterly Other Operating Expenses came in at $90.2 million in Q4 2025, up 314.13% quarter-over-quarter from $21.8 million in Q3 2024.

Vericel (VCEL) Other Operating Expenses (2011 - 2025) Analysis & Trends

Vericel has disclosed Other Operating Expenses across 7 years of filings, most recently posting $90.2 million for Q4 2025.

  • Other Operating Expenses for Q4 2025 came in at $90.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $90.2 million (up 116.63% YoY), and the FY2025 annual result was $90.2 million, changed N/A from the prior year.
  • Other Operating Expenses came in at $90.2 million for Q4 2025 at Vericel, up from $21.8 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $90.2 million in Q4 2025 to a low of $19.9 million in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 90.20 Mn
Sep 30, 2024 21.78 Mn
Jun 30, 2024 19.86 Mn
Dec 31, 2016 2.64 Mn
Dec 31, 2014 1.64 Mn
Sep 30, 2014 -7.29 Mn
Jun 30, 2014 -9.03 Mn
Dec 31, 2013 -14.71 Mn
Sep 30, 2013 -9.16 Mn
Jun 30, 2013 -11.26 Mn
Mar 31, 2013 2,000.00
Dec 31, 2012 -2,000.00
Mar 31, 2012 2,000.00
Sep 30, 2011 2,000.00
Mar 31, 2011 2,000.00